Association Between Dysfunctional Complement Factor I: Rare Variant Status and Progression to Advanced AMD Outcomes

Related

• 

  Expert Panel: Pegcetacoplan Safety

  Andre J. Witkin, MD

  David A. Eichenbaum, MD, FASRS

  Samuel Anthony Minaker, MD, MSc

  Janani Singaravelu, MS, MD

  Sunir J. Garg, MD, FACS, FASRS

  Annual Meeting Talks

  2024

• 

  Medical Case Conference: Jaclyn Kovach, MD, FASRS

  Jaclyn L. Kovach, MD, FASRS

  Annual Meeting Talks

  2024

• 

  Treatment of Geographic Atrophy Secondary to AMD With Pegcetacoplan: Two-Year Outcomes From the Randomized Phase 3 DERBY and OAKS Trials

  Charles C Wykoff, MD, PhD, FASRS

  Updates from the Field

  2022